TUSC2 and central nervous system cancer: Overall, the current findings strongly suggest that TUSC2 is a novel glioma tumor suppressor that is frequently lost in gliomas due to miRNA-mediated downregulation and proteasomal degradation, with TUSC2 overexpression leading to glioma suppression.